Glucosidase, Alpha, Acid (GAA) (N-Term) Peptide
Quick Overview for Glucosidase, Alpha, Acid (GAA) (N-Term) Peptide (ABIN8101557)
Target
Origin
Source
Application
-
-
Protein Region
- N-Term
-
Purpose
- GAA Peptide - N-terminal region
-
Sequence
- RDLAPTPGAN LYGSHPFYLA LEDGGSAHGV FLLNSNAMDV VLQPSPALSW
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti- GAA Antibody (ARP44227_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- GAA (Glucosidase, Alpha, Acid (GAA))
-
Background
-
Background Information: This gene encodes lysosomal alpha-glucosidase, which is essential for the degradation of glycogen to glucose in lysosomes. The encoded preproprotein is proteolytically processed to generate multiple intermediate forms and the mature form of the enzyme. Defects in this gene are the cause of glycogen storage disease II, also known as Pompe's disease, which is an autosomal recessive disorder with a broad clinical spectrum. Alternative splicing results in multiple transcript variants.
Alternative Symbols: LYAG
-
Molecular Weight
- 104 kDa
-
Gene ID
- 2548
-
NCBI Accession
- NP_000143
-
UniProt
- P10253
Target
-
